STOCK TITAN

GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

GenMark Diagnostics (NASDAQ: GNMK), a leader in automated multiplex molecular diagnostics, announces participation in the Cowen 41st Annual Health Care Conference on March 1, 2021, at 2:00 p.m. ET. The event will be virtual, and interested parties can access the live and archived webcast on their investor relations site.

GenMark specializes in enhancing patient care and reducing healthcare costs through its proprietary eSensor® technology. Their systems, such as the eSensor XT-8® and ePlex®, address diverse infectious disease testing needs.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference.

GenMark’s management team is scheduled to present in a virtual setting on Monday, March 1st, 2021 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com

ABOUT GENMARK
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit genmarkdx.com

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com



FAQ

When is GenMark Diagnostics participating in the Cowen 41st Annual Health Care Conference?

GenMark Diagnostics will participate in the Cowen 41st Annual Health Care Conference on March 1, 2021, at 2:00 p.m. ET.

How can I access the webcast for GenMark Diagnostics' conference presentation?

You can access the live and archived webcast of GenMark Diagnostics' conference presentation at ir.genmarkdx.com.

What does GenMark Diagnostics specialize in?

GenMark Diagnostics specializes in automated multiplex molecular diagnostic solutions to enhance patient care and reduce healthcare costs.

What technologies does GenMark use in its diagnostic systems?

GenMark uses proprietary eSensor® detection technology in its diagnostic systems, including the eSensor XT-8® and ePlex®.

What types of infections can GenMark's systems test for?

GenMark's systems can test for a broad range of infectious diseases, including respiratory, bloodstream, and gastrointestinal infections.

GNMK

NASDAQ:GNMK

GNMK Rankings

GNMK Latest News

GNMK Stock Data

70.15M
Surgical and Medical Instrument Manufacturing
Manufacturing